Who Owns McKesson Provider Technologies?
McKesson Provider Technologies is owned by McKesson Corporation, a publicly traded American healthcare company headquartered in Irving, Texas. McKesson Provider Technologies operates as the technology solutions division of McKesson, providing healthcare IT software and services to health systems, physician practices, and healthcare providers across North America.
Parent Company
McKesson Corporation
Founded
2001
Status
Publicly Traded
Headquarters
Irving, Texas, USA
Who Owns McKesson Provider Technologies?
- Parent Company: McKesson Corporation
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: MCK
| Brand | Parent Company | Ownership Type |
|---|---|---|
| McKesson Provider Technologies | McKesson Corporation | Wholly owned |
History of McKesson Provider Technologies
- Founded: 2001
- Founders: McKesson Corporation (internal development)
McKesson Provider Technologies was established in 2001 as McKesson's dedicated healthcare IT and software solutions division. The division was created to serve the growing demand for electronic health records, pharmacy management systems, and clinical decision support tools from healthcare providers.
The division's foundation was strengthened through strategic acquisitions and partnerships. In 2005, McKesson Provider Technologies acquired Medcon, Ltd., an Israeli company providing web-based cardiac image and information management solutions. This acquisition expanded the division's capabilities in diagnostic imaging and workflow management.
Throughout the 2000s and 2010s, McKesson Provider Technologies expanded its software portfolio and customer base, becoming one of the largest healthcare IT providers in North America. The division developed specialized expertise in serving different healthcare provider types including large health systems, independent physician practices, and home care agencies.
In 2013, McKesson acquired a 50% stake in Germany-based Celesio for $8.3 billion, further expanding its international healthcare IT and distribution capabilities. This strategic investment strengthened McKesson's position in European healthcare markets.
In recent years, McKesson Provider Technologies has focused on cloud-based solutions, interoperability, and advanced analytics. The division has invested in artificial intelligence and machine learning capabilities to enhance clinical decision support and operational efficiency for healthcare providers.
About McKesson Corporation
What does McKesson do?
McKesson distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and Canada. The company also operates the US Oncology Network, distributes medical-surgical supplies, and provides technology solutions to biopharma manufacturers through its Prescription Technology Solutions segment.
Is McKesson publicly traded?
Yes, McKesson Corporation trades on the New York Stock Exchange under ticker symbol MCK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group and BlackRock.
What is McKesson's annual revenue?
In fiscal year 2024 (ended March 31, 2024), McKesson reported revenue of approximately $308.9 billion, a 10% increase from the prior fiscal year. The U.S. Pharmaceutical segment accounted for approximately $275 billion of total revenue.
Who is McKesson's CEO?
Brian Tyler has served as Chief Executive Officer of McKesson since April 2019, succeeding John Hammergren. Tyler has led the company's strategic focus on oncology and biopharma services as higher-growth businesses within the healthcare distribution ecosystem.
When was McKesson founded?
McKesson was founded in 1833 by John McKesson and Charles Olcott in New York City as Olcott & McKesson, making it one of the oldest continuously operating companies in the United States.
What is McKesson's role in the opioid settlement?
McKesson, along with Cencora and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. McKesson's share of the settlement is approximately $7.9 billion, to be paid over 18 years.
- Founded: 1833
- Headquarters: Irving, Texas, USA
- Company Type: Publicly Traded
- Stock: NYSE: MCK
- Revenue: approximately $354 billion (FY2025, year ended March 2025)
- Employees: Approximately 51,000
Where Is McKesson Provider Technologies Made / Based?
- Headquarters: Irving, Texas, USA
- Manufacturing / Operations: United States
McKesson Provider Technologies Sustainability & Ethics
McKesson Provider Technologies operates under McKesson Corporation's comprehensive sustainability framework, integrating environmental responsibility, ethical business practices, and social impact into its healthcare IT solutions and operations. As one of North America's largest healthcare IT providers, serving 50% of all US health systems, McKesson Provider Technologies demonstrates commitment to sustainable healthcare technology while maintaining its position as a leader in healthcare innovation and digital transformation.
Environmental Sustainability and Climate Action: McKesson Corporation has established comprehensive environmental initiatives through its "Our Planet" pillar, focusing on delivering environmental action for health. The company engages with leading organizations including the National Academy of Medicine, Collaborative for Healthcare Action to Reduce MedTech Emissions, Sustainable Purchasing Leadership Council, and the World Business Council for Sustainable Development to reduce greenhouse gas emissions across healthcare operations. McKesson Provider Technologies contributes to these goals through energy-efficient data center operations, sustainable software development, and environmentally responsible IT infrastructure management.
Healthcare IT Environmental Impact: McKesson Provider Technologies addresses the environmental impact of healthcare technology through sustainable data center design, cloud computing optimization, and energy-efficient software solutions. The company's healthcare IT platforms help reduce the environmental footprint of healthcare delivery by enabling digital health records, telehealth solutions, and automated workflows that minimize paper usage and transportation requirements for healthcare delivery.
Ethical Business Practices and Data Privacy: As a healthcare IT provider serving sensitive patient data and critical healthcare systems, McKesson Provider Technologies maintains the highest standards of data privacy, security, and ethical business practices. The company's healthcare IT solutions comply with HIPAA, HITECH, and other healthcare regulations while ensuring robust protection of patient information and healthcare system integrity.
Supply Chain Responsibility and Sustainable Healthcare: McKesson Provider Technologies contributes to sustainable healthcare supply chains through inventory management systems, pharmaceutical tracking solutions, and healthcare logistics optimization. The company's IT solutions help healthcare providers reduce waste, improve inventory management, and optimize resource allocation, contributing to more sustainable healthcare delivery systems.
Community Health and Social Impact: Through McKesson's "Our Community" pillar, McKesson Provider Technologies supports initiatives that enhance the health of communities through technology-enabled healthcare solutions. The company's healthcare IT platforms help improve access to care, support underserved populations, and enable more efficient healthcare delivery that benefits community health outcomes.
Employee Engagement and Workplace Sustainability: McKesson Provider Technologies operates under McKesson's "Our People" initiatives, providing dynamic opportunities for employees to thrive while promoting workplace sustainability and ethical business practices. The company's healthcare IT professionals are engaged in developing solutions that address both business needs and social responsibility in healthcare technology.
Partnership and Collaboration Sustainability: Through McKesson's "Our Partners" framework, McKesson Provider Technologies collaborates with healthcare providers, technology partners, and community organizations to improve health outcomes while maintaining sustainable business practices. These partnerships focus on creating healthcare technology solutions that are both environmentally responsible and socially beneficial.
Climate Change Position and Reporting: McKesson Corporation maintains a comprehensive Climate Change Position Statement and publishes detailed impact reports, including the FY25 Corporate Impact Report. McKesson Provider Technologies contributes to these climate commitments through sustainable IT operations, energy-efficient technology solutions, and transparent reporting of environmental performance metrics.
Innovation for Sustainable Healthcare: McKesson Provider Technologies drives innovation in healthcare IT that supports sustainable healthcare delivery, including telehealth platforms, digital health records, and automated systems that reduce the environmental impact of healthcare while improving patient outcomes and operational efficiency.
Awards & Recognition
McKesson Provider Technologies has received significant recognition for its leadership in healthcare IT, market dominance, and contributions to healthcare technology innovation. As McKesson Corporation's healthcare IT division, the brand benefits from the parent company's extensive achievements and industry recognition while maintaining its specific focus on healthcare information technology solutions.
Market Leadership Recognition: McKesson Provider Technologies serves 50% of all US health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds, making it one of the largest healthcare IT providers in North America. This market dominance has been recognized by industry analysts and healthcare organizations as demonstrating exceptional reach and influence in healthcare technology.
Healthcare IT Innovation Awards: McKesson Provider Technologies has been acknowledged for its innovative healthcare IT solutions that transform healthcare delivery through technology. The company's electronic health record systems, practice management software, and healthcare analytics platforms have received recognition for improving healthcare efficiency, patient outcomes, and operational performance across healthcare organizations.
Digital Health Leadership: The company's contributions to digital health transformation have been recognized by healthcare technology organizations and industry publications. McKesson Provider Technologies' role in enabling telehealth, remote patient monitoring, and digital healthcare delivery has been acknowledged as particularly significant during and following the COVID-19 pandemic.
Healthcare Analytics and Data Excellence: McKesson Provider Technologies has received recognition for its healthcare analytics and data management solutions that help healthcare providers leverage data for improved decision-making and patient care. The company's ability to turn healthcare data into actionable insights has been acknowledged as a key differentiator in the healthcare IT market.
Interoperability and Standards Leadership: The company has been recognized for its contributions to healthcare interoperability and standards development, helping create seamless data exchange between healthcare systems. McKesson Provider Technologies' work in developing and implementing healthcare data standards has been acknowledged as advancing healthcare IT integration and efficiency.
Customer Satisfaction and Implementation Excellence: McKesson Provider Technologies has achieved recognition for customer satisfaction and successful implementation of healthcare IT solutions across diverse healthcare environments. The company's ability to support healthcare organizations through digital transformation has been acknowledged as demonstrating exceptional service and technical expertise.
Cybersecurity and Data Protection Recognition: In an era of increasing healthcare cyber threats, McKesson Provider Technologies has been acknowledged for its robust cybersecurity solutions and data protection measures that safeguard patient information and healthcare systems. The company's commitment to healthcare IT security has been recognized as essential for maintaining trust in digital healthcare solutions.
Healthcare Industry Partnership Awards: McKesson Provider Technologies has received recognition for successful partnerships with healthcare organizations, technology companies, and industry associations. These collaborations have been acknowledged as advancing healthcare IT innovation and creating integrated solutions that address complex healthcare challenges.
Corporate Social Responsibility Recognition: Through McKesson Corporation's broader corporate social responsibility programs, McKesson Provider Technologies has been acknowledged for its contributions to community health, employee well-being, and sustainable business practices in healthcare technology.
McKesson Provider Technologies Recalls & Controversies
McKesson Provider Technologies, as part of McKesson Corporation, has faced significant controversies primarily related to the parent company's role in the opioid crisis and regulatory challenges in pharmaceutical distribution. While the healthcare IT division itself has maintained relatively clean operations, it has been affected by reputational and legal challenges stemming from McKesson's broader business activities.
Baltimore Opioid Lawsuit Verdict (November 2024): McKesson Corporation, McKesson Provider Technologies' parent company, was found liable in a major lawsuit filed by the city of Baltimore regarding the opioid crisis. In November 2024, a jury awarded Baltimore $266 million in its case against McKesson and Cencora (formerly AmerisourceBergen), accusing the distributors of fueling an epidemic of opioid addiction. The city alleged that several pharmaceutical companies, manufacturers, and distributors didn't do enough to prevent opioid addiction from becoming an epidemic in Baltimore.
DEA Testimony and Regulatory Scrutiny: In September 2024, DEA agents testified that McKesson ignored glaring flags of opioid problems in Baltimore, with lawyers for the city arguing that opioid distributors were irresponsible in how they kept track of pharmacy orders. This testimony revealed that McKesson continued shipping to pharmacies with suspicious opioid orders, contributing to dangerous amounts of prescription drugs reaching Baltimore streets in the late 2000s and 2010s.
Opioid Settlement Obligations: McKesson Corporation has faced significant financial obligations related to opioid crisis settlements across multiple jurisdictions. The company has agreed to substantial settlements with various states and municipalities, creating financial impacts that affect all McKesson divisions, including Provider Technologies. These settlements have totaled billions of dollars and continue to affect the company's financial performance and reputation.
Regulatory Compliance Challenges: McKesson Provider Technologies operates in a highly regulated healthcare environment, facing ongoing compliance requirements related to healthcare data privacy (HIPAA), electronic health records standards, and healthcare IT regulations. The company must maintain continuous compliance with evolving healthcare regulations while managing the reputational impact of parent company controversies.
Healthcare IT Market Competition: McKesson Provider Technologies faces intense competition in the healthcare IT market from companies like Epic Systems, Cerner (Oracle Health), and other healthcare technology providers. This competitive pressure creates ongoing challenges in maintaining market share and technological leadership while addressing broader corporate controversies.
Data Privacy and Security Concerns: As a major healthcare IT provider handling sensitive patient data, McKesson Provider Technologies faces ongoing scrutiny regarding data privacy and cybersecurity. While the division has maintained strong security practices, it operates in an environment of increasing concern about healthcare data breaches and privacy violations.
Supply Chain and Distribution Controversies: McKesson Provider Technologies is indirectly affected by controversies related to McKesson's pharmaceutical distribution business, including questions about supply chain practices, drug pricing, and distribution ethics. These issues can impact the healthcare IT division's relationships with healthcare providers and partners.
Reputational Impact on Healthcare IT Sales: The opioid crisis controversies and negative publicity surrounding McKesson Corporation have potentially impacted McKesson Provider Technologies' ability to secure new healthcare IT contracts and maintain relationships with healthcare providers concerned about corporate ethics and social responsibility.
Legal and Financial Risk Management: McKesson Provider Technologies must manage legal and financial risks associated with parent company litigation and settlements, including potential impacts on division resources, employee morale, and strategic planning. These broader corporate challenges require careful risk management and communication strategies.
Healthcare Industry Trust and Credibility: The opioid crisis controversies have affected trust in McKesson Corporation across all business divisions, including McKesson Provider Technologies. The healthcare IT division must work to maintain credibility with healthcare providers while addressing concerns about corporate ethics and social responsibility.
Brands Owned by McKesson Corporation
- Biologics by McKesson - Independent specialty pharmacy providing personalized patient care for oncology ...
- Health Mart - Independent pharmacy franchise network with over 4,500 member pharmacies across ...
- McKesson Medical-Surgical - Medical supplies and equipment distribution brand providing healthcare products ...
McKesson Provider Technologies Ownership: Pros & Cons
Advantages
- +Comprehensive healthcare IT platform integrating pharmacy, clinical, and administrative functions
- +Extensive customer base providing stability and network effects
- +Significant investment in research and development for healthcare technology
- +Integration with McKesson's pharmaceutical distribution and supply chain services
- +Advanced security and compliance infrastructure for healthcare data
- +Scalable solutions serving organizations from small practices to large health systems
Considerations
- -Dependency on McKesson's corporate policies and strategic direction
- -Competition from other healthcare IT vendors and cloud-based solutions
- -Complex healthcare IT regulatory environment and compliance requirements
- -Pressure on healthcare IT margins from consolidation and pricing pressures
- -Ongoing investment required for system upgrades and interoperability
- -Limited flexibility in certain product decisions due to corporate structure
Frequently Asked Questions About McKesson Provider Technologies
Sources & Further Reading
- McKesson Corporate Impact & Responsibility -
- McKesson Environmental Action for Health -
- McKesson FY25 Corporate Impact Report -
- McKesson Climate Change Position Statement -- Corporate environmental commitments and reporting
- Reuters: Baltimore Opioid Lawsuit Coverage -
- WBALTV: Baltimore Opioid Settlement News -
- WYPR News: DEA Agent Testimony -
- New York Times: Opioid Crisis Coverage -
- Opioid Settlement Tracker -
- HIMSS Healthcare IT Awards -
- Healthcare Information and Management Systems Society -- Industry standards and recognition
- TechTarget: McKesson Corporation Definition -
- Healthcare Distribution Alliance Industry Recognition -
- Healthcare IT News and Industry Publications -- Market analysis and competitive intelligence
- HIPAA and Healthcare IT Regulations -- Compliance and regulatory information
- Healthcare Analytics and Data Management Resources -- Industry best practices and standards
- Digital Health and Telehealth Organizations -- Industry associations and professional groups
Where to Buy
Disclosure: We may earn commission from purchasesCompetitors to McKesson Provider Technologies
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Takeda | Japan | 2011 | Mass market | Global | All-ages | |
| Novartis | Switzerland | 2009 | Mass market | Global | All-ages | |
| Cardinal Health | USA | 2014 | Mass market | United states | All-ages | |
| Cardinal Health | USA | 2010 | Mass market | United states | All-ages | |
| Cvs Health | USA | 1982 | Mass market | United states | All-ages | |
| Merck | USA | 2014 | Premium | Global | All-ages |
Learn More About Competitors

Adcetris
Owned by Unknown Company
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.

Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.

Cardinal Health At-Home
Owned by Cardinal Health
At-home healthcare solutions provider delivering medical supplies, equipment, and pharmacy services directly to patients' homes owned by Cardinal Health.

Cardinal Health Specialty Pharmacy
Owned by Cardinal Health
Specialty pharmaceutical distribution and services provider serving specialty pharmacies, hospitals, and healthcare providers with complex medications owned by Cardinal Health.

Coram
Owned by CVS Health
American specialty pharmacy and infusion services provider offering home and alternate site care, owned by CVS Health.

Keytruda
Owned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Competitive Analysis
Market Positioning: McKesson Provider Technologies competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
McKesson Corporation Stock Information
Jobs at McKesson Corporation
Latest News About McKesson Provider Technologies
Related Articles About McKesson Provider Technologies
View more articlesMonthly M&A Roundup: April 2026 Brand Ownership Changes
Global M&A reached a record $1.3 trillion in Q1 2026, and April is continuing the momentum. McCormick is buying Unilever's food business for $45 billion. Paramount and Warner Bros. Discovery are merging. Here is every major brand ownership shift entering April 2026.
How Sony Built Its Entertainment Empire
Sony started making rice cookers and radio repair equipment in 1946. Today it owns PlayStation, Columbia Pictures, Sony Music, and the world's largest music publishing catalogue. Here is the full story.
The Story Behind the Coca-Cola Acquisition Strategy
Coke, Sprite, Fanta, Minute Maid, Powerade, Dasani, Smartwater, Costa Coffee, Fuze Tea, and over 200 more brands all share one parent. Here is how The Coca-Cola Company quietly became a total beverage company.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.

Acuvue
Johnson & Johnson's contact lens brand, launched in 1988 as the world's first disposable contact lens and now the global market leader in daily disposable lenses.

Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.